Heidelberg University Hospital Becomes Focus For Zika Virus Research In Germany
Posted June 14 2017
The interdisciplinary research alliance “ZIKAlliance” will receive around 10 million euros of funding from the EU until 2019. 1.15 million euros of that money will be allocated to two research projects at the Heidelberg University Hospital led by Prof. Dr. Ralf Bartenschlager and Dr. Thomas Jänisch. This makes Heidelberg University Hospital one of the main centers for Zika virus research in Germany.

“ZIKAlliance” unites more than 50 partners from Europe, Asia and South America from different disciplines, all doing research on the Zika virus which is already present in 73 countries worldwide. In Heidelberg, Dr. Thomas Jänisch will collect reliable data on Zika virus infections with pregnant women. In addition, he collects all the data and bio samples from three Zika consortia funded by the EU in order to assess them equally and to make them accessible for different research projects.


Dr. Thomas Jänisch and Prof. Dr. Ralf Bartenschlager (Heidelberg University Hospital) lead two research projects of the
EU-funded ZIKAlliance


Based on his results on the closely related Dengue virus, Prof. Dr. Ralf Bartenschlager, Director Molecular Virology at the Department of Infectious Diseases, and his team will investigate how the Zika virus takes control over parts of human cells and which effect the subsequent changes have for the disease.


Please find more information in the press release issued by Heidelberg University Hospital (in German only): 



Doris Rübsam-Brodkorb

Head of Communications

Tel: +49 6221 56-5052

doris.ruebsam-brodkorb [ aT ] 


Julia Bird

Media Relations

Tel: +49 6221 56-7071

julia.bird [ aT ] 


Further information online:


Section Clinical Tropical Medicine: 

Molecular Virology at the Department of Infectious Diseases: